A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin

Publisher： Karger

E-ISSN： 1662-6575|4|2|327-335

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.2, 2011-06, pp. : 327-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatic Arterial Infusion Chemotherapy with Epirubicin in Patients with Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 188-193

Karger

Access to resources Recommend Favorite

Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: A pilot study

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 3, 2015-09 ,pp. : e6-e12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of 3‐D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 6, 2015-06 ,pp. : 607-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma

By  

Oncology, Vol. 80, Iss. 3-4, 2011-06 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization

By  

Oncology, Vol. 89, Iss. 3, 2015-05 ,pp. : 167-174

Karger

Access to resources Recommend Favorite